Return On Equity of Lomond Therapeutics Holdings, Inc. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary: Lomond Therapeutics Holdings, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2022 to 30 Sep 2025.
Lomond Therapeutics Holdings, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -105%, a 138% decline year-over-year.
Lomond Therapeutics Holdings, Inc. annual Return On Equity for 2024 was -3450%, a 600% decline from 2023.
Lomond Therapeutics Holdings, Inc. annual Return On Equity for 2023 was 690%, a 34527% increase from 2022.

Return On Equity, Quarterly (%)

Return On Equity, YoY Quarterly Change (%)

Return On Equity, Annual (%)

Return On Equity, YoY Annual Change (%)

Lomond Therapeutics Holdings, Inc. Quarterly Return On Equity (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q3 2025	-105%	-379%	-138%	01 Jul 2025	30 Sep 2025
Q2 2025	-138%	-456%	-143%	01 Apr 2025	30 Jun 2025
Q1 2025	-209%	-565%	-159%	01 Jan 2025	31 Mar 2025
Q4 2024	-3450%	-4140%	-600%	01 Oct 2024	31 Dec 2024
Q3 2024	274%	+272%	+14570%	01 Jul 2024	30 Sep 2024
Q2 2024	318%	+316%	+15000%	01 Apr 2024	30 Jun 2024
Q1 2024	355%	+353%	+16603%	01 Jan 2024	31 Mar 2024
Q4 2023	690%	+688%	+34527%	01 Oct 2023	31 Dec 2023
Q3 2023	2%	-1%	-43%	01 Jul 2023	30 Sep 2023
Q2 2023	2%			01 Apr 2023	30 Jun 2023
Q1 2023	2%			01 Jan 2023	31 Mar 2023
Q4 2022	2%			01 Oct 2022	31 Dec 2022
Q3 2022	3%			01 Jul 2022	30 Sep 2022

Period	Value	YoY Chg	Change %	Start Date	End Date
2024	-3450%	-4140%	-600%	01 Jan 2024	31 Dec 2024
2023	690%	+688%	+34527%	01 Jan 2023	31 Dec 2023
2022	2%			01 Jan 2022	31 Dec 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.